Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Hesperadin: From Aurora B Mechanism to Translation
2026-08-28
Hesperadin offers translational researchers a practical way to connect Aurora B kinase activity with histone H3 phosphorylation, chromosome behavior, checkpoint dynamics, and polyploidization. This article integrates product-level biochemical and cellular evidence with findings on Plk1-regulated mitotic checkpoint complex disassembly to define rigorous experimental strategies, interpret phenotypes, and identify the boundaries between mechanistic research and therapeutic inference.
-
Methyl-β-cyclodextrin: Practical Membrane Workflow
2026-08-28
Methyl-β-cyclodextrin, also called methyl beta cyclodextrin, is a soluble biochemical reagent for controlled membrane cholesterol extraction and related membrane studies. It is intended for research workflows only, not diagnostic or medical use, and requires empirical optimization because no directly matched paper evidence is available for a product-specific protocol.
-
PDHA1 Succinylation and Immune Escape in Cholangiocarcinoma
2026-08-27
The reference study defines a metabolic–immune mechanism in which PDHA1 K83 succinylation increases alpha-ketoglutarate accumulation, activates macrophage OXGR1–MAPK signaling, and suppresses MHC-II antigen presentation in cholangiocarcinoma. Its pharmacological findings suggest that inhibiting this modification may improve the response to gemcitabine and cisplatin, while also identifying important considerations for interpreting TCA-cycle metabolite experiments.
-
β-Pseudouridine Workflows for saRNA Research
2026-08-27
Use β-Pseudouridine as a controlled RNA-modification reagent, analytical standard, and mechanistic comparator—not as an automatic substitute for a pseudouridine triphosphate in transcription reactions. This workflow connects RNA structure, translational fidelity, and self-amplifying RNA assay design while separating product chemistry from platform-level vaccine effects.
-
Afatinib in Gastric Cancer Assembloid Research
2026-08-26
Afatinib, also known as BIBW 2992, can serve as a mechanistic probe for EGFR–ErbB signaling in patient-derived gastric cancer assembloids. This article explains how to distinguish direct kinase-dependent effects from stromal modulation and design more informative cancer biology research assays.
-
HyperScript RT SuperMix for qPCR in BPD Workflows
2026-08-26
Translate circRNA and mRNA findings from hyperoxia-induced bronchopulmonary dysplasia models into reproducible cDNA synthesis and two-step qRT-PCR workflows. HyperScript™ RT SuperMix for qPCR combines a thermally stable reverse transcriptase with Oligo(dT)23 VN and random primers, supporting structured or low-input RNA while simplifying assay setup.
-
FOXM1–ERα Networks in Female Lung Adenocarcinoma
2026-08-25
This study integrates transcriptomic, survival, immune, and cellular analyses to investigate FOXM1 as a biomarker and functional regulator in female lung adenocarcinoma. Its proposed FOXM1–hsa-miR-204-5p–DGCR5–ERα network offers a hypothesis for linking tumor biology with immunotherapy-related stratification, although parts of the ceRNA model remain incompletely validated.
-
UHRF1, DNA Methylation, and Osteogenesis in SOP
2026-08-25
The reference study connects UHRF1-dependent DNA 5-methylcytosine modification with super-enhancer redistribution and TGM2-regulated autophagic flux in senile osteoporosis. Its multi-omics and validation framework provides a mechanistic model for how epigenetic disruption in mesenchymal stem cells can suppress bone formation and identifies the UHRF1–TGM2 axis as a potential intervention point.
-
EPZ5676: Practical DOT1L Inhibition Workflows
2026-08-24
EPZ5676 enables a focused workflow from SAM-competitive DOT1L biochemistry to H3K79 methylation and cell-growth readouts. This guide connects MLL-rearranged leukemia assays with a carefully bounded renal-fibrosis research application, emphasizing controls, timing, solubility, and interpretation.
-
D-Luciferin Sodium Salt for Interpretable Imaging
2026-08-24
D-Luciferin sodium salt is a firefly luciferase substrate for ATP-dependent light production in live-cell and animal studies. This guide focuses on interpreting signal correctly, with practical assay decisions for CAR macrophage and oncology research rather than repeating a basic product overview.
-
Berberine, Tuft Cells, and Estrogen-Deficiency Bone Loss
2026-08-23
A 2026 Phytomedicine study identifies an underappreciated gut–bone mechanism in which berberine increases intestinal butyrate, activates GPR41, and expands tuft cells. In ovariectomized rodent models, this remodeling improved barrier function and corrected the Th17/Treg imbalance associated with estrogen deficiency, providing a mechanistic framework for postmenopausal bone-loss research.
-
CP-673451: Selective PDGFRα/β Inhibitor Workflow
2026-08-22
CP-673451 is a selective PDGFRα/β inhibitor for connecting receptor phosphorylation, PDGF-BB-driven angiogenesis, and tumor phenotypes in one research program. This guide translates its nanomolar activity into practical cell-based, angiogenesis, and xenograft workflows while using ATRX status to sharpen glioma study design.
-
BIBP 3226: A Receptor-Level Arrhythmia Tool
2026-08-22
BIBP 3226 trifluoroacetate provides a receptor-level way to test NPY/Y1R and NPFF signaling in adipose-neural cardiac models. This article translates recent arrhythmia findings into a staged assay strategy, practical controls, and evidence-aware interpretation.
-
Large-Scale Gastruloid Arrays for Developmental Screening
2026-08-21
Jan and colleagues developed an indexed magnetic microraft array that supports culture, imaging, automated sorting, and downstream molecular analysis of individual human gastruloids at scale. The platform distinguished euploid from aneuploid gastruloids and linked altered DNA density with increased NOG and KRT7 expression, providing a practical framework for screening heterogeneous developmental phenotypes.
-
10 mM dNTP Mixture: From PCR to Assay Design
2026-08-20
Explore how a 10 mM dNTP mixture supports controlled DNA synthesis, PCR, and sequencing workflows. This guide connects nucleotide standardization with recent mechanistic insights into LNP trafficking while separating validated evidence from practical assay recommendations.